Effexor XR Fact Sheet
Wyeth; patent expires 2008. IR version available as generic.
Major Depression
- Generalized Anxiety Disorder
- Social Anxiety Disorder
- Panic Disorder
Serotonin and Norepinephrine Reuptake Inhibitor
XR formulation supplied in 37.5 mg, 75 mg, and 150 mg capsules; IR (immediate release) formulation supplied in 25 mg, 37.5 mg, 50 mg, 75 mg, and 100 mg tablets.
- "Magic dose" to aim for: 150 mg, which is the dose at which norepinephrine reuptake inhibition kicks in.
- Give patient two things: 1) "starter pack" (one week each of 37.5 mg and 75 mg) and 2) a prescription for 150 mg Q PM.
- Evening dosing works well for most patients, taking advantage of initial sedative effects.
- Geriatric patients tend to tolerate same dosing schedule as younger patients.
Most common are nausea, dizziness, fatigue, sexual dysfunction.
- Treatment-emergent BP elevation is possible at higher doses, uncommon with doses below 300 mg.
- Black Box Warning: In clinical trials, SSRIs and SNRIs increased the risk of suicidality in children (from 2% to 4%). No actual suicides occurred in these trials.
- Pregnancy Risk Category C
Only significant interactions are that Wellbutrin and Benadryl can increase Effexor serum levels.
Effexor may be more effective than SSRIs in bringing about complete remission of depressive symptoms, though more recent studies are calling this into question.
Current Issue
Topics
Search
Follow Us
Earn CME Credit Instantly!
Not quite ready for a one-year subscription to The Carlat Psychiatry Report? Need CME credits on a particular topic or on a tight deadline?
Try our A la Carte CME! You can buy single or multiple credits of continuing education, without committing to a year-long newsletter subscription.
Click here to purchase A la Carte CME credits
Already an A la Carte subscriber? Click here to go to your a la carte page
Steve Balt Interviewed by NPR
Our own Steve Balt was interviewed on NPR's "Talk of the Nation" on psychiatry's shift toward drugs and away from talk therapy.
Editor-in-Chief
After 10 years at the helm of TCPR, Dr. Carlat has handed over editor-in-chief duties to Dr. Steve Balt. We’re excited to welcome him aboard! Read More...
The 2012 Carlat Atypical Antipsychotics Table is Now Available!
With all the atypicals on the market, it's hard to keep track of indications, dosages, and all the other relevant facts for each drug. Use this table for summaries on these meds, their uses, their side effects, and a whole slew of other information.
TCPR Continuing Education
Accredited/Approved/Accepted by:
- ACCME
- AMA
- APA
- ABPN
- ANCC
- AAPA